Skip to main content
  • M-TEER Safe, Effective Option for Degenerative MR Patients: CLASP IID Trial

    Two-year results from the CLASP IID Randomized Trial and Registry confirm the sustained safety and effectiveness of the PASCAL system in treating a broad population of degenerative mitral regurgitation (DMR) patients. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details